← Back to Search
Chitosan Coated PLGA Nanoparticles Amplify The Ocular Hypotensive Effect Of Forskolin: Statistical Design, Characterization And In Vivo Studies.
N. Khan, Ameeduzzafar, Kushagra Khanna, A. Bhatnagar, F. Ahmad, Asif Ali
Published 2018 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
PURPOSE Enhancing the ocular hypotensive effect of forskolin (FK) by means of biodegradable chitosan (CS) coated poly lactic-co-glycolic acid (PLGA) nanoparticles (NP's). METHODS One step emulsion-sonication process was employed for the formulation of CS-PLGA NP's with optimization being carried out by employing a four factor four level Box Behnken Design. The physical and spectral characterization, drug release, permeation, confocal and ocular tolerance studies (ex-vivo &in vivo) were performed. The corneal retention was assessed by gamma scintigraphic analysis and dexamethasone induced glaucamotous rabbit's intraocular pressure (IOP) was measured by means of Schiotz tonometer. RESULTS AND DISCUSSION Particle size of optimized CS-PLGA NP's was found as 201.56 ± 10.92 nm with a good PDI and positive zeta potential value. Entrapment efficiency and drug loading were found to be 72.32 ± 1.12% and 28.39 ± 1.67% respectively. Spectral characterization confirmed the purity and encapsulation of the drug within polymeric system. Sustained drug release and enhanced permeation profile was observed with maximum depth penetration. Ocular tolerance studies explicated its safe use. Scintigraphy studies indicated longer retention of CS-PLGA NP's while increased effectiveness after single instillation in reducing the intraocular pressure was observed. CONCLUSION CS-PLGA-NP's could be successfully formulated and are an excellent vehicle for FK in ocular delivery.
This paper references
High-resolution 2D 1H-15N NMR characterization of persistent structural alterations of proteins induced by interactions with silica nanoparticles.
M. Lundqvist (2005)
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
M. Ravi Kumar (2004)
Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy.
K. Wang (2015)
Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery
Dongzhi Hou (2016)
The number of people with glaucoma worldwide in 2010 and 2020
H. Quigley (2006)
The pathophysiology and treatment of glaucoma: a review.
R. Weinreb (2014)
An Injectable Oxygen Release System to Augment Cell Survival and Promote Cardiac Repair Following Myocardial Infarction
Zhaobo Fan (2018)
Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: Optimization, in vitro characterization and stability assessment
Devina Verma (2017)
Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.
R. S. Bhatta (2012)
Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends
Puwang Li (2011)
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
N. Nafee (2007)
Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
M. A. Kalam (2017)
Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study
N. Sharma (2016)
A new long acting ophthalmic formulation of carteolol containing alginic acid.
O. Sechoy (2000)
HET-CAM test for determining the possible eye irritancy of pesticides.
P. Budai (2010)
Stability-Indicating HPTLC Method of Carteolol in Bulk Drug and in Pharmaceutical Dosage Forms
Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization
G. Mustafa (2015)
PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
Mohammed Halayqa (2014)
Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery
Y. Wang (2013)
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
H. Gupta (2010)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.
Hirenkumar K. Makadia (2011)
Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac
Shuai Shi (2015)
Charge‐Reversal Polymers for Biodelivery
Bo Zhang (2014)
Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
M. Warsi (2014)
Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid – in vitro and in vivo assessment
D. P. Maurya (2011)
Dissolution Method Development for Poorly Soluble Compounds
B. Rohrs (2001)
Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Preparation and Characterization of Polymeric Nanoparticles: An Interdisciplinary Experiment
M. J. Ramalho (2016)
Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
J. Vandervoort (2004)
Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
I. Pang (2001)
Comparative study of chitosan- and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids
M. Durán‐Lobato (2015)
Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator.
N. Burstein (1984)
In Situ Gelling Gelrite/Alginate Formulations as Vehicles for Ophthalmic Drug Delivery
Yuejiang Liu (2010)
Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations
Y. Zubairu (2015)
Efficacy and safety of 1% forskolin eye drops in open angle glaucoma – An open label study
M. Majeed (2015)
Progress in the characterization of bio-functionalized nanoparticles using NMR methods and their applications as MRI contrast agents.
R. López-Cebral (2014)
Chitosan and its use as a pharmaceutical excipient.
L. Illum (1998)
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
M. Mohammed (2017)
Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits
Sohail Akhter (2013)
Glaucoma, “the silent thief of sight”: patients’ perspectives and health seeking behaviour in Bauchi, northern Nigeria
M. Abdull (2016)
PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study
A. K. Sah (2017)
Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system.
Gaurav K. Jain (2011)
Forskolin lowers intraocular pressure by reducing aqueous inflow.
J. Caprioli (1984)
Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design
B. Gajra (2014)
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations
Faithful Makita-Chingombe (2016)
Forskolin: upcoming antiglaucoma molecule.
Vijay D. Wagh (2012)
Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
J. Pandit (2017)
In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
M. Malhotra (1997)
Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
Zhaobo Fan (2017)
Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies.
Anjali Singh (2013)
Development and validation of UPLC/ESI-Q-TOF-MS for carteolol in aqueous humour: Stability, stress degradation and application in pharmacokinetics of nanoformulation
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
R. Mainardes (2005)
Design of biodegradable particles for protein delivery.
A. Vila (2002)
Biodegradable Polymers for Ocular Drug Delivery
H. Kimura (2001)
Effect of Conditions of Preparation on the Size and Encapsulation Properties of PLGA-mPEG Nanoparticles of Cisplatin
E. C. Gryparis (2007)
The Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery
Xudong Yuan (2010)
Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Mohd Abul Kalam (2016)
Polymeric nanosuspensions for enhanced dissolution of water insoluble drugs
R. Yadollahi (2013)
This paper is referenced by
Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model
M. A. Safwat (2020)
BBD-Based Development of Itraconazole Loaded Nanostructured Lipid Carrier for Topical Delivery: In Vitro Evaluation and Antimicrobial Assessment
Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
M. Shahab (2020)
Glaucoma: Current treatment and impact of advanced drug delivery systems
K. S. Yadav (2019)
Thermoresponsive sol-gel improves ocular bioavailability of Dipivefrin hydrochloride and potentially reduces the elevated intraocular pressure in vivo
Musaed Alkholief (2020)
Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Antonella Rozaria Nefeli Pontillo (2019)
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium
Mona G. Arafa (2020)
Repurposing Itraconazole Loaded PLGA Nanoparticles for Improved Antitumor Efficacy in Non-Small Cell Lung Cancers
Nabil A Alhakamy (2019)
Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
May N Bin-Jumah (2020)
Biofabrication of Chitosan-Based Nanomedicines and Its Potential Use for Translational Ophthalmic Applications
Riddhi Vichare (2020)
Preparação de nanopartículas de PLGA contendo carboplatina e sua funcionalização com folato de quitosana
Daniel de Moraes Profirio (2018)
Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment.
Neeraj Mittal (2019)
Core-shell lipid-polymer nanoparticles as a promising ocular drug delivery system to treat glaucoma
Y. Zhou (2020)
Design of chitosan-based particle systems: A review of the physicochemical foundations for tailored properties.
L. B. Ferreira (2020)
Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design, In-vitro Characterization, Antibacterial Evaluation and Scintigraphy Study
The therapeutic potential of the labdane diterpenoid forskolin
Bahare Salehi (2019)
Clarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects
A. A. Öztürk (2019)
Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment
Nabil K. Alruwaili (2020)
The Therapeutic Potential of the Labdane
Bahare Salehi (2019)
Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
R. B. Singh (2020)
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
Alexandra Zamboulis (2020)
Advances and limitations of drug delivery systems formulated as eye drops.
Clotilde Jumelle (2020)
Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity
T. Ahmed (2020)
New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles
Behiye Şenel (2019)
Nanosystems for the Encapsulation of Natural Products: The Case of Chitosan Biopolymer as a Matrix
Anastasia Detsi (2020)
Surface Modification of Nanoparticles: Methods and Applications
Gopikrishna Moku (2019)